Zacharon Pharma Raises $3.5 Million

Zacharon Pharmaceuticals Inc., a San Diego-based developer of small-molecule glycan inhibitors, has raised $3.5 million in Series A funding from Avalon Ventures. It also received more than $2.2 million in NIH research grants.

North AmericaUSBriefs